GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » S Biomedics Co Ltd (XKRX:304360) » Definitions » General and Admin. Expense

S Biomedics Co (XKRX:304360) General and Admin. Expense : ₩1,775 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is S Biomedics Co General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. S Biomedics Co's General and Admin. Expense for the three months ended in Mar. 2024 was ₩514 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩1,775 Mil.

S Biomedics Co General and Admin. Expense Historical Data

The historical data trend for S Biomedics Co's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

S Biomedics Co General and Admin. Expense Chart

S Biomedics Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
General and Admin. Expense
Get a 7-Day Free Trial 331.31 952.87 581.74 698.66 1,228.52

S Biomedics Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 349.22 391.10 414.44 455.38 513.59

S Biomedics Co General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,775 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

S Biomedics Co General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of S Biomedics Co's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

S Biomedics Co (XKRX:304360) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » S Biomedics Co Ltd (XKRX:304360) » Definitions » General and Admin. Expense
Comparable Companies
XKRX:378800 XKRX:049960 XKRX:217950 XKRX:086820 XKRX:352770 XKRX:341170 XKRX:263050 XKRX:244460 XKRX:288330 XKRX:203690 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
Seongsui-ro 26-gil, 4th Floor, Wooil Venture Town Building 28, Seongdong-gu, FedEx building, Seoul, KOR, 04797
Website
https://www.sbiomedics.com
S Biomedics Co Ltd researches and develops cell therapies for regenerative biomedicine. It owns two platform technologies: Functionally Enhanced Cell Spheroid and Targeted Embryonic Stem Cell Differentiation for developing cell therapy products that overcome the limitations of existing cell therapy products.

S Biomedics Co (XKRX:304360) Headlines

No Headlines